Sleep Physiology and Polysomnogram, Physiopathology and Symptomatology in Sleep Medicine by Kayabekir, Murat
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Sleep Physiology and 
Polysomnogram, Physiopathology 
and Symptomatology in Sleep 
Medicine
Murat Kayabekir
Abstract
Over recent years, the importance of sleep physiology and pathology has 
been better understood in terms of correct diagnosis, treatment, prognosis 
and innovative research of diseases. Sleep disorders are often confused with 
clinical symptoms of adult and pediatric medical conditions. In medicine, 
electrophysiological signal recording methods are very important for establish-
ing a correct diagnosis especially in neurological sciences. Polysomnography 
(PSG) is a golden standard diagnostic method that records electrophysiological 
signals used for sleep physiology and diseases. When the medical disciplines 
and diseases that make use of this diagnostic method are considered, its 
significance becomes clearer. For example, medical disciplines benefit-
ing from PSG are as follows: “Clinical Physiology, Neurology, Ear Nose and 
Throat, Dentistry, Psychiatry, Pulmonology, Cardiology, Pediatric Neurology, 
Pediatric Cardiology, Internal Medicine, Neurosurgery, Endocrinology, etc.” 
The patient groups diagnosed with PSG are as follows: “Sleep Disordered 
Breathing (Central Sleep Apnea Syndrome, Obstructive Sleep Apnea 
Syndrome), Obesity, Morbid Obesity, REM Behavior Disorder, Restless Leg 
Syndrome, Rhythm Disorders, Epileptic Disorders, Insomnia, Insomnia 
and Headache, Hypersomnia, Narcolepsy, Secondary Hypertension, etc.” 
Interpretation and understanding electrophysiological signals correctly show 
us interactions of body systems with sleep physiology and integrated thera-
peutic approaches to sleep disorders. In conclusion; new approaches to sleep 
pathophysiology depend on a better understanding and further advancement of 
polysomnography.
Keywords: electrophysiology, awake, sleep, mechanism, PSG, correct diagnosis, 
innovation
1. Introduction
Electrophysiological signal recordings are used in medicine for research, clini-
cal diagnosis and follow-up of diseases as well as for providing guidance to their 
treatment. For example; “Electrocardiogram (ECG)” is used daily as inpatient 
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and as outpatient, it is the most basic electrophysiological signal recording in 
which five waves (P, Q, R, S, and T) are interpreted. When all monitorization 
activities performed at the bedside of the patient are taken into consideration, 
recording electrophysiological signals with well-calibrated equipment and cor-
rect interpretation of the obtained results by doctors and healthcare staff seems 
to be at the crossroads of correct diagnosis, follow-up and treatment. In sleep 
monitorization, electrophysiological signal recordings are performed by multiple 
electrodes and provide us with important clinical information. In fact, monitor-
ing wakefulness as much as sleep is quite important in clinical practice; it helps 
to establish a correct diagnosis in clinical practice and sometimes provides the 
opportunity to have access to unsuspected information. If PSG could be used as 
frequently as ECG by well-trained medical doctors and healthcare personnel in 
sleep medicine, sleep health and sleep disorders of the individuals in the society 
could be understood much better. Therefore, health could be evaluated not only 
in wakefulness but also in sleep leading to a continuum. During its preliminary 
years, sleep related studies attracted the attention of physiologists and as time 
passed clinical information regarding sleep disorders increased significantly and 
the possibility to treat all these diseases brought the attention of clinicians into 
this field. For human physiology and especially for the central nervous system to 
continue its functioning; there needs to be a healthy interaction and an organism 
specific balance between wakefulness and sleep cycles. Sleep is a physiologi-
cal need; a state where the response of the brain to environmental stimuli has 
stopped reversibly. The insufficiency or absence of this need negatively influ-
ences the interactions in the neuronal circuits and pathways that are responsible 
for the wakefulness of the brain. It is very well known that many functions of the 
organism change during sleep and different physiological mechanisms come into 
play during NREM and REM sleep. Diseases also show changes during sleep and 
during NREM and REM phases. Electrophysiological studies could assist in the 
understanding of basic mechanisms in neurological sciences. Electrophysiological 
methods and PSG that are geared to understand the nights as well as the days 
aim at not only establishing correct diagnosis and delineating pathophysiological 
mechanisms but also engaging in innovation and developing novel diagnostic and 
therapeutic methods.
2.  Sleep physiology and polysomnogram, physiopathology and 
symptomatology in sleep medicine
2.1 Sleep physiology and polysomnogram in sleep medicine
Sleep is a physiological and behavioral process that an individual requires to 
carry out his daily functions. This process is completed in a regular and con-
tinuous manner every night. As a part of biological rhythm, human brain has 
a healthy functioning by differentiating dark and day hours of the day. From 
controlling hormone levels to muscle tone, from regulating pace of breathing to 
contents of our thought; sleep influences all bodily and mental functions. It is not 
surprising that sleep can make these changes happen in the body because sleep 
causes significant changes in the electrical activity of the brain as a whole [1]. 
Sleep characterizes itself by not responding to one’s surroundings and by drifting 
away from perception; yet it is a reversible behavior. During 1940–1950, physi-
ologists believed that sleep was initiated as a result of tiredness that developed 
during the day and by a slowing down in the activation of the fore brain from 
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weakening in the activation of the reticular activating system. Later, based on 
transection studies, brain stem was shown to be responsible for generating sleep 
especially studies in cats; where total sections performed on pontine tegmentum 
induce sleeplessness. Physiologist Nathaniel Kleitman was working at Chicago 
University and he discovered REM sleep together with his colleague Dement 
in 1959 leading to a revolution in the field of sleep medicine. Two colleagues 
demonstrated the nature of sleep and the relation of eye movements with sleep 
by recording spontaneous whole night sleep. During their observations, it was 
understood for the first time that sleep consisted of 90–120 minutes cycles, it 
first got deep and then became superficial, and that during this superficial stage 
rapid eye movements appeared and then sleep deepened once again. Through the 
same series of observations it was found that, during the first half of the night 
deep sleep was more frequent and that REM sleep constituted 20–25% of the total 
length of the sleep [2, 3]. Sleep has an important function in an individual and 
sleep deprivation for a couple of days can hinder an individual’s cognitive and 
physical performance, general productivity and health. The vital role of sleep 
on homeostasis can be clearly demonstrated by the possible death of rats who 
suffer from sleep deprivation for 2–3 weeks. Despite the obvious importance of 
sleep, we still have limited information about why it is an obligatory part of life. 
Sleep has two main types of physiological effects: First, its effect on the nervous 
system itself and second its effects on other functional systems of the body. There 
is no doubt that the effects on the nervous system are important. Long lasting 
wakefulness generally leads to progressive impairments of thought processes 
and even to abnormal behavioral activities (thoughts are blurred, as the duration 
of wakefulness lengthens irritability and psychosis ensues). Therefore, sleep is 
considered to protect the normal order of brain activity by different means and 
to preserve the normal “balance” between the different functions of the central 
nervous system [4, 14].
2.1.1 Mechanisms of wakefulness and sleep
In the regulation of wakefulness and sleep brain stem, hypothalamus, 
basal fore brain and their neurotransmitters all play a role. When we analyze 
the neuroanatomy of wakefulness and sleep, we mainly see that neurons activat-
ing wakefulness and sleep are located at pontis oralis, mesencephalic central 
tegmentum, posterior hypothalamus and midline brain stem, dorsolateral 
medulla reticular formation and anterior hypothalamic-preoptic fields at dif-
ferent concentrations and different localizations. Brain stem and reticular 
formation are important anatomic localizations. Wakefulness is managed by 
reticular activating system (RAS). RAS is localized in the pons and midbrain. 
RAS stimulates the cortex by ventral and dorsal tracts. Ventral tract stimulates 
the frontal parts of the brain through hypothalamus and subthalamus, dorsal 
tract stimulates the cortex through the nucleus groups in the thalamus. During 
wakefulness transmission of sensory information from thalamus is permitted 
through RAS control managed by thalamus. During sleep, the activity of RAS 
stops and the transmission of sensory information through thalamus is blocked 
and the stimulation of cortex is prevented. Anatomic structures responsible 
for the hypothalamic control of sleep and wakefulness: for wakefulness, stimuli 
originating from rostral pons and caudal midbrain regions reach paramedian 
midbrain in diencephalon and here the signals divide into two paths aiming to 
reach thalamus and hypothalamus. Main structures projecting to thalamus are 
PedunculoPontine Tegmental (PPT) and LateroDorsal Tegmental (LDT) nuclei 
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that are of cholinergic nature. The structure that initiates sleep is thought to be 
the ventrolateral preoptic nucleus (VLPO) located on the anterior part of the 
hypothalamus. VLPO nucleus suppresses the activities of brain stem, pons and 
locus coeruleus, dorsal raphe nucleus, laterodorsal tegmental pedunculopontine 
tegmental nucleus via GABA and galanin neurotransmitters. Suprachiasmatic 
Nucleus (SCN) is known as the light sensitive circadian pacemaker. Throughout 
daytime light stimulus is transmitted from retina to hypothalamus through neu-
ral pathways and results in secretion of melatonin from the pineal gland. It is an 
anatomical structure that has a central role in maintaining the day-night rhythm 
[3–5, 10]. Neurotransmitters controlling sleep and wakefulness can be listed as: 
“Glutamate, Acetylcholine, Histamine, Norepinephrine and GABA”. Reticular 
activating system stimulates the cortex by using glutamate while ponto-mesen-
cephalic tegmental neurons do the same job by using acetylcholine. Neurons at 
locus coeruleus use mostly norepinephrine, these extend from the brain stem to 
the cerebral cortex by including the fore brain, and they activate the stimulation 
of the cortex and contribute to maintaining sleep. Cholinergic neuronal network 
results in wakefulness in two types of cortexes: (1) It projects to laterodorsal 
tegmental and pedunculopontine tegmental nuclei, midline and intralaminar 
thalamic nuclei and to a lesser degree to lateral hypothalamus and basal for brain. 
(2) Cholinergic neuron group starts from the basal for brain and has a wide-
spread projection to cortex. This pontomesencephalic neuron group is part of the 
ascending reticular activating system; they not only play a part in the activation 
during wakefulness but also are actively involved in paradoxical sleep. Glutamate 
is another excitatory neurotransmitter; it acts as the primary neurotransmitter of 
the ascending reticular activating system. Glutamate is found at a very high con-
centration at the brain stem reticular formation. This neurotransmitter plays an 
active role in the wakeful brain and is secreted from the cortical cells to a signifi-
cant degree throughout wakefulness. During slow wave sleep “burst discharges” 
appear due to the activation of special glutamate receptors. Histamine also plays 
an important role in wakefulness. Neurons containing histamine are found in 
tuberomammillary nuclei and in posterior hypothalamus. Noradrenergic neurons 
(locus coeruleus), have diffuse projections in the brain that extend to the cortex. 
Histaminergic neurons are associated with cortical activation during wakefulness 
whereas they are shut down during REM sleep. To sleep there needs to be a shift 
from sympathetic regulation to parasympathetic regulation. Parasympathetic 
centers of significance are found in “solitary tract nucleus neurons, anterior 
hypothalamus and preoptic fields”. Serotonergic raphe neurons facilitate the 
initiation of sleep while GABA-ergic neurons inhibit the activating system. These 
GABA-ergic neurons are selectively activated during slow wave sleep. As a result 
of this inhibition, brain stem, hypothalamus and nasal fore brain are suppressed 
and disfacilitation (inhibition) and hyperpolarization of thalamocortical system 
takes place. Thereby from the wakeful state where we see rapid, tonic discharges 
on EEG, the system shifts to sleep state we start recording sleep spindles and slow 
wave activity. Initiation and continuation of slow wave sleep is made possible 
by lengthening and strengthening the inhibition of the activating system with 
GABA-ergic system [1, 4–11].
2.1.2 Normal sleep
Sleep is a complex mix of physiological and behavioral processes. Typically, 
sleep takes place while the individual is in a horizontal position, immobile 
with closed eyes and when all other indicators point out to sleep. There are two 
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distinct stages of sleep: The one with non-rapid eye movements (NREM) and 
the one with rapid eye movements (REM). These stages are differentiated from 
one another and from wakefulness with clear margins. NREM sleep is classi-
cally divided into three stages based on EEG. EEG patterns usually consist of 
a mixture of synchronous sleep spindles, regular waves like K-complexes and 
high voltage slow waves. Based on the depth of sleep, there are three NREM 
stages, during the first two stages, wake-up thresholds are generally low and 
during the third stage it is at its highest or a body that can move and for a brain 
that can regulate, NREM sleep is a relatively inactive state going together with 
minimal and fragmental activity. On the other hand, during REM stage, the 
body is immobile because of muscular atonia, in EEG shows activation and 
episodic rapid eye movements can be observed. Sleep cycle starts with NREM 
(calm, synchronized sleep, deep wave sleep); nearly every 90 minutes NREM 
and REM (mobile, desynchronized, paradoxical sleep) follow one another. 
Slow wave sleep dominates the first one third of the night and is related to the 
duration of wakefulness before sleep. REM sleep dominates the last one-third 
portion of the night and is related to the circadian rhythm. First stage of sleep, 
namely NREM-1 lasts only for a couple of minutes after the initiation of sleep 
and it goes together with low wake-up threshold and provides the transition 
from wakefulness to sleep. NREM-2 stage of sleep is identified by the presence 
of sleep spindles and K-complexes on EEG. To wake-up, there needs to be a more 
intense stimulus during NREM-2 compared to NREM-1. If stimuli given during 
NREM-1 are administered during NREM-2, there is no arousal; but K-complexes 
will appear. NREM-2 gradually progresses to high voltage slow activity and 
transforms into NREM-3 stage. In a young healthy individual, the percentage 
of slow waves in sleep pattern should be 20–50%. NREM-REM cycles of sleep 
follow throughout the night by repetitions. First NREM-REM cycle lasts about 
70–100 minutes, the second and further cycles last around 90–120 minutes. In 
young adults, during the first one third of the night deep sleep is predominantly 
seen during NREM stage, whereas during the last one-third portion of the night 
REM sleep dominates. Short wake-up periods usually happen when shifting to 
REM sleep [10, 11].
2.1.3 Electrophysiological signal recordings of wakefulness and sleep
During wakefulness electroencephalogram (EEG) reflects an active cerebral 
cortex engaged in perception and cognitive functions that shows relatively low 
voltage, high frequency and rapid activity. The discharge by a single neuron or 
a single nerve fiber can never be recorded from the scalp surface. Only when 
thousands even millions of neurons or fibers are simultaneously fired, electri-
cal potentials pertaining to a single neuron or a single fiber can be recorded as 
this much of an electrical potential would suffice to make such a measurement 
from scalp surface [1]. When eyes are closed, several neurons show synchronous 
discharges at a frequency of 12 per second constituting alpha waves. When the 
eyes are opened afterwards, the activity of the brain increases to a greater degree; 
but the synchronicity of the signals decrease which leads to the canceling out of 
the brain waves. As a result of this, weak waves of higher but irregular frequency 
which are called beta waves appear. If the cortex does not have any connection 
with the thalamus, then alpha waves are not generated. Stimulation of non-specific 
reticular nuclei that surround thalamus and stimulation of diffuse nuclei that are 
located inside the thalamus result in the generation of waves in the thalamocorti-
cal system with a frequency of 8–13 per second which is the natural frequency for 
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alpha waves. That is why it is possible that alpha waves appear from the spontane-
ous negative feedback impulses in the diffuse thalamocortical system that also 
includes brain stem activating system. Delta waves include all the waves in EEG 
that have a frequency of less than 3–5 per second. They appear during very deep 
sleep, they also appear in the experimental animal studies where cortex has been 
separated from the thalamus with a subcortical section. Therefore, delta waves can 
appear in the cortex independent of the activities in the lower parts of the brain. 
Sleep spindles are produced by the thalamus. They appear as 12–15 Hz oscilla-
tions in between slow waves during NREM sleep in human EEGs. The production 
mechanism of these oscillations is related to the degree of hyperpolarization in 
thalamocortical cells. While shifting from wakefulness to sleep, the membrane 
potentials of thalamocortical cells are exposed to a progressive hyperpolariza-
tion, thus synaptic responsiveness decreases and sensory information transfer 
is prevented. When a sufficient level of hyperpolarization is achieved, we start 
seeing rhythmic bursting in nucleus reticularis neurons belonging to thalamus at 
a frequency interval which is in correlation with sleep spindle. Furthermore, slow 
wave oscillations due to membrane hyperpolarization also take place. It is accepted 
that sleep homeostasis is significantly affected by the size and characteristics of the 
sleep spindles that are formed [11–14].
2.1.4 Polysomnogram and polysomnography
“Polysomnography” “PSG” is the recording of sleep via electrophysiological 
signals. Sleep recordings that appear on a sheet of paper or on a computer screen 
are called “Polysomnogram”. Throughout one night electrophysiological signals 
recorded during wakefulness and sleep are as follows: “Electroencephalogram 
(EEG), electromyogram (EMG; jaw, arm and leg), electrooculogram (EOG), 
electrocardiogram (ECG), snoring, oro-nasal air flow (L/s) (liter/second) chest and 
abdomen movements (respiratory effort recordings), O2 saturation, and body posi-
tion and real time-video-image recordings”. “Penile tumescence, gastroesophageal 
reflux and blood pressure” are other electrophysiological signals that are recorded, 
despite not being performed for all patients. Polysomnography is the procedure 
where different physiological or pathophysiological parameters are recorded during 
sleep for six or more hours, evaluation of these by a medical doctor and generation 
of a report (Figure 1).
Polysomnography is performed for two main purposes: (1) Understanding 
physiological (normal) sleep and meanwhile demonstrating the changes that 
take place in the organism (for example heart rate changes can be analyzed) 
Figure 1. 
Examination of a polysomnogram by a medical doctor.
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(2) Identification of abnormal events that take place during sleep; diagnosis of 
different sleep disturbances, guide in their treatments. PSG starts by explain-
ing the procedure to the patient in great detail. The patient should understand 
that there would not be any pain involved with the procedure, that no medica-
tions would be used. The patients are informed that their natural sleep will 
be recorded through superficial electrodes to be placed on their bodies. The 
patients should be reminded that they would not be spending the night by 
themselves, and that a technician would be present to follow the process from 
a monitor. After the patient puts on his sleepwear, electrodes are placed for an 
overnight sleep test and calibration process is initiated. First, the calibration 
of PSG equipment is made. This is performed before the electrodes are placed. 
Afterwards the electrodes are calibrated. This is done after the electrodes are 
placed in the electrode box. Lastly, physiological calibration is performed. 
This calibration is performed via the electrodes that transmit physiological 
changes through EEG, EOG, and EMG, leg movements, chest and abdomen 
movements. The PSG records of electrophysiological signals features are as 
follows (Figure 2): EEG recordings during PSG: Gold and silver electrodes are 
used for sleep EEG. It is important to clean the skin where the electrodes are to 
be placed. This is performed to decrease the resistance between the skin and 
the electrodes. Another important issue is to use substances that would increase 
the conductivity of the electrodes and to make sure that electrodes stay in place 
Figure 2. 
The PSG records of electrophysiological signals.
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throughout the night. Most commonly used fixer is “collodium”. For PSG, it is 
recommended to have recordings from at least three channels. These channels 
are F4-M1, C4-M1 and O2-M1. M1 is placed on the left mastoid process. To these 
electrodes, F3, C3, O1 and M2 electrodes are attached as back up. If one of the 
electrodes mentioned above gets bad during the night, then F3-M2, C3-M2 
and O1-M2 derivations are used. Here, M2 corresponds to the right mastoid 
process. Additionally, Fz-Cz, Cz-Oz and C4-M1 derivations can be used for EEG 
recordings. For this spare electrodes Fpz, C3, O1 and M2 need to be placed. EOG 
recordings during PSG: The objective of having electrooculography recordings 
during polysomnography is to identify the eye movements. This recording is in 
fact the recording of the voltage difference between cornea and retina. With the 
movement of the eye, the distance from the retina and cornea to the electrodes 
changes and creates a dipole. This change is recorded with EEG. Two EOG 
electrodes are used in PSG recordings. E1 is located 1 cm below the left lateral 
canthus E2 is placed 1 cm above the right lateral canthus. Both electrodes are 
referred to the electrode (M2) placed on the left mastoid process. That means 
EOG is recorded from two channels as E1-M2 and E2-M2. Alternatively, E1-Fpz 
and E2-Fpz can be used. EMG recordings during PSG: In polysomnography, 
electromyography (EMG) is of importance in detecting R stage (REM sleep). 
This recording is different than a classical EMG. It is performed to assess stri-
ated muscle tone. Using three electrodes is recommended for this recording; 
only two of these are used to do the recording. Superficial electrode is placed 
on the mandible and is referred to either of the electrodes placed below this. In 
polysomnography it is sufficient to have only one channel for EMG recording. 
Respiratory Effort Recordings in PSG: In polysomnography, there needs to be at 
least three respiratory parameters recorded: “oro-nasal air flow (L/s) chest and 
abdomen movements and O2 saturation”. Recording of stopping air flow (apnea) 
is performed by oronasal thermal sensors. For the recording of respiratory 
effort, inductance plethysmography method is used. For the measurement of O2 
saturation, pulse oximetry that identifies the O2 saturation of hemoglobin in the 
capillary blood would be the most appropriate method. Recording of Periodical 
Leg Movements (PLM) during Sleep in PSG: Superficial electrodes are placed on 
the anterior tibial muscle. Two electrodes should be placed to each leg (active, 
passive) and one channel should be recorded from each leg adding up to two 
channels. Peak to peak amplitude of the EMG activity that is generated in the 
absence of movement should be 4–6 microvolts, at least four movements should 
take place with 5–90 seconds intervals and each of these movements should take 
0.5–5 seconds to fulfill the criteria for PSG diagnosis of periodic limb move-
ment disorder. Multiple Sleep Latency Test-MSLT: This is the electrophysiological 
signal recording method used to objectively evaluate daytime sleepiness. This 
is a polysomnographic recording obtained during daytime and a half to 3 hours 
after waking up from a nocturnal polysomnogram. It should consist of five tests 
of 20 minutes duration, which are 2 hours apart from each other. Two basic data 
for evaluation: (1) Time of sleep onset (2) Appearance of REM sleep throughout 
the recording process. REM of short duration that appears during recording is 
defined as SOREM (Sleep Onset REM). MSLT; is part of the clinical evaluation 
for narcolepsy and idiopathic hypersomnia.
2.1.5 Recording and scoring of sleep
Scoring of sleep corresponds to staging of sleep. For the staging of sleep polysom-
nography recordings are separated into 30 second-long intervals (epoch); each epoch 
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is scored with a sleep stage. Sleep stages are as follows: “Stage N1 (or NREM1), Stage 
N2 (or nREM2), Stage N3 (or NREM3), Stage R (REM), Stage W (wakefulness)”. 
Each 30 second interval needs to match with one of these stages. Three main electro-
physiological signals are used when sleep stages are identified: “EEG, EMG, EOG”. 
There three parameters are evaluated for each epoch and one sleep stage is matched 
with each 30 second interval. There are certain rules to be respected when staging 
of sleep is performed: Stage N1: it is generally regarded as the stage where the shift 
from wakefulness to sleep happens (sleep initiation stage). If more than one half of 
an epoch consists of low amplitude and mixed frequency EEG activity that replaces 
alpha rhythm, this part is staged as Stage N1. In an individual who does not have any 
alpha activity during wakefulness, seeing only one of the following three features 
in EEG is sufficient to categorize that part as Stage N1: (1) Baseline activity in EEG 
should be at least 1 Hz lower than that is seen during wakefulness. (2) Observing 
sharp vertex waves on EEG (in central regions with duration of shorter than 500 ms, 
waves with sharp edges). (3) Slow eye movements should appear in EOG (lasting 
longer than 500 ms, conjugated, regular, and sinusoidal) (Figure 3). Stage N2: it is 
the longest portion of sleep both in terms of duration and proportion. In EEG, the 
presence of either a sleep spindle or K-complex results in naming that stage as Stage 
N2 (Figure 4). Stage N2 sleep starts in this manner and despite the absence of K 
complex and/or sleep spindles, the stage continues being N2 until further changes 
take place in the epoch (Stage W, N3, R or arousals). Only when there is a progress 
to Stage W, Stage 3 or Stage R or when an arousal appears, Stage N2 is concluded. 
Stage N3: It is called as slow wave sleep. In EEG, it is seen as delta activity with a 
frequency of 0.5–2 Hz and with amplitude that is more than 75 microvolts. During 
this stage there can be sleep spindles and K complexes. The only criterion for Stage 
N3 is the presence of slow waves (delta wave oscillations) in more than 20% of this 
part (Figure 5). Stage R: indicates REM sleep. In terms of central nervous system 
functioning this is a completely different stage of sleep. Three features are required 
in the epoch to be called Stage R (1). In EEG the wave activity is of low amplitude 
Figure 3. 
Stage-N1.
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and mixed frequency (2). In jaw EMG, there is a low basal EMG activity which is 
the lowest of all stages (3) In EOG rapid eye movements are observed (rapid eye 
movements—REM; these are eye movement shorter than 500 ms in duration, when 
are conjugate, irregular, sharp spike eye movements). In epochs that follow Stage 
R, even in the absence of rapid eye movements, if the other two rules remains, it 
continues to be classified as Stage R (Figure 6).
Figure 5. 
Stage-N3.
Figure 4. 
Stage-N2.
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2.1.6 Recording and scoring of breathing during sleep
American Academy of Sleep Medicine (AASM) has published the rules for 
scoring sleep, sleep associated events as well as respiratory events. Based on 
these rules, abnormal respiratory occurrences that are observed during sleep are 
“apnea, hypopnea, arousal associated with respiratory effort, hypoventilation 
and Cheyne-Stokes breathing”. Electrophysiological signal recordings that are 
required for interpreting respiratory problems in PSG are: “O2 saturation, nasal/
oronasal air flow (nasal cannula, thermistor), thoracic, abdominal respiratory 
effort, EEG recordings (absolutely required to identify arousal), body position, 
tracheal microphone, ECG, leg EMG recordings”. To detect respiratory effort 
the following methods are used: (1) Measurement of thoracic and abdominal 
movements, this is the most widespread method used in the sleep laboratories to 
detect the respiratory effort. (2) Respiratory muscle EMG, standard electrodes 
are placed into intercostal spaces. These can be mixed with ECG recordings. 
This is the oldest method available. (3) Pleural pressure, esophageal pressure is 
measured to measure the inspiratory effort. Patients cannot tolerate esophageal 
balloons. Newer, thin, piezoelectric transducers with catheter tips are better 
tolerated. Esophageal pressure measurements are very helpful in two instances: 
(a) Identification of central apnea and hypopnea with a high sensitivity (b) The 
diagnosis of upper respiratory tract resistance syndrome. However this method 
is uncomfortable.
Apnea scoring: Apnea starts with a net loss of breathing amplitude when 
signals coming from nasal cannula as an alternative to oronasal thermistor stops 
and it ends with the start of the first breath that comes close to the basal value. 
Apnea is scored based on the following criteria: (1) 90% or more of a decrease 
in the peak signal of the thermal sensor compared to the basal amplitude. (2) 
Having an incident of at least 10 seconds duration. (3) At least 90% of the 
incident fulfilling the amplitude decrease criteria required for apnea scoring. 
Figure 6. 
REM sleep.
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Based on respiratory effort, there are three types of apnea: (1) Obstructive 
apnea: apnea during a respiratory effort. (2) Central apnea: apnea criteria and 
the absence of respiratory effort during the period where air flow stops. (3) 
Mixed apnea: apnea criteria that start with an absence of respiratory effort and 
follows with a continuing increase in respiratory effort. Hypopnea scoring: It is 
performed based on following criteria: (1) More than 30% of a decrease in the 
signal amplitude of the nasal cannula compared to the baseline. (2) The episode 
lasting for at least 10 seconds. (3) 4% or more of a decrease in the O2 saturation 
compared to the baseline saturation. (4) At least 90% of the incident should 
satisfy the amplitude decrease parameters accepted for hypopnea. Apnea index 
(AI): defines the number of apneas that occur within an hour while sleeping. 
Apnea-hypopnea index (AHI): defines the total number of apneas and hypop-
neas combined during an hour while sleeping. Respiratory effort related arousal 
(RERA) scoring: arousal resulting from 10 seconds or longer of flattening of 
the inspiratory portion of nasal pressure which does not fulfill the criteria for 
hypopnea or apnea. Respiratory disturbance index (RDI): it defines the sum-
mation of apnea, hypopnea and RERA incidents that appear in an hour during 
sleep. Hypoventilation scoring: if PaCO2 increases more than 10 mmHg during 
sleep compared to levels obtained in supine position during wakefulness this is 
scored as hypoventilation. Cheyne-Stokes breathing is score: when there are at least 
three consecutive crescendo and decrescendo breathing changes, with at least 
one of the following criteria: (1) five or more central apnea or hypopnea during 
an hour of sleep (2) breathing amplitude changes in crescendo-decrescendo style 
in a consecutive manner lasting at least 10 minutes (3) Cheyne-Stokes breathing 
cycle lasting for 60 seconds in general, but variable. O2 saturation measurement: 
measurement of O2 saturation is generally performed with pulse oximetry. 
It detects the O2 saturation of hemoglobin in the capillary blood through the 
emission and absorption of light generated from a source. O2 desaturation index 
(ODI): it defines the number of oxyhemoglobin desaturation incidents per hour 
seen during sleep [15–18].
2.2 Physiopathology and symptomatology in sleep medicine
2.2.1 Relationship of sleep with body systems and diseases
Cardiovascular system: known hemodynamic measurements “heart rate, heart 
rate variations, blood pressure, cardiac output, baroreflex activity and peripheral 
vascular resistance” provides us important information as to how the cardiovas-
cular system functions in sleep as well as in wakefulness. In NREM and REM 
stages of sleep, due to parasympathetic system activation heart rate, blood 
pressure, cardiac output and peripheral vascular resistance decreases. Lowest 
levels of arterial blood pressure are seen during Stage N3. The decrease in the 
heart rate is related to the decrease in the sympathetic motor tone. During NREM 
sleep; blood pressure, respiratory rate and basal metabolic rate decrease by 
10–30%, this is the most comforting and most restful period of deep sleep. In the 
hemodynamic changes in sleep, arterial baroreflex mechanism is thought to play 
a regulating role. Baroreflex arch consists of peripheral receptors (sinus caroticus 
and arcus aorta), central neurons (tractus solitorius and medulla oblongata) and 
afferent and efferent (sympathetic, parasympathetic) neurons. The decrease in 
blood pressure is compensated with an increase in the heart rate centrally 
through this reflex arch, or vice versa. From a cardiovascular perspective, during 
NREM sleep, there is relative autonomic stability, sympathetic inhibition, and 
increase of vagal (parasympathetic) tone. It is also the stage where bradycardia 
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and respiratory sinus arrhythmia is seen. Despite the fact that there is parasym-
pathetic predominance during REM sleep, due to bursting in sympathetic 
nervous system, blood pressure increases and variations are observed in the heart 
rate. During this stage, first degree or Wenckebach type second degree AV 
blocks, and sinus blockage can take place due to increased vagal tone. During 
Stage N3 blood pressure decreases by 10–20% and heart rate by 5–10% (dipper). 
The absence of the expected nocturnal decrease in blood pressure is called 
non-dipper, while a decrease of extreme scale is called extreme dipper and both 
can lead to cardiovascular events. Compared to NREM, blood pressure is higher 
during REM sleep; myocardial infarction, unstable angina, cardiac death, 
ventricular tachyarrhythmias, pulmonary embolism, cerebrovascular incidents 
and sudden cardiac death can take place during REM stage of sleep that intensi-
fies during early hours of the day during which there is autonomic instability 
(sudden sympathetic discharge) triggering platelet aggregation, plaque rupture 
and coronary spasm [19–25]. Respiratory system: control mechanisms for respira-
tion during sleep: (1) homeostatic and metabolic control; O2 and CO2 sensitivity 
mechanisms on carotid bodies through chemoreceptors provide for the regularity 
of breathing. (2) Behavioral (cortical) control; during activities like speaking or 
swallowing breathing is controlled voluntarily. (3) Wakefulness warning; during 
wakefulness reticular activating system sends non-tonic stimuli to the respira-
tory center in the brain stem resulting in an increase in breathing. NREM and 
REM stages are controlled with metabolic stimuli. It is shown that respiratory 
response by chemoreceptors decreases during NREM and this decrease gets more 
significant during REM. The main stimulus for respiration is PaCO2, the effector 
organ is the lungs, and the chemoreceptors that regulate the response to stimuli 
are located on carotid bodies and brain stem. The system operates with stimuli 
and feedback mechanisms. For example, during heart failure the response to 
stimulus is delayed as a result of lengthened circulatory time. Likewise, a minor 
change in ventilation can result in a significant change in CO2 and can cause 
impairment in respiratory balance. Instances where the tendency to central apnea 
increases in the organism are: (1) During transition to sleep; when CO2 is at a 
level that is lower than that is required to stimulate respiration and the number of 
respiration becomes insufficient. (2) When the ratio between respiratory 
response and respiratory stimuli is high; idiopathic sleep apnea is an example for 
this. (3) Lengthened circulatory time; for example during cardiac failure typi-
cally Cheyne-Stokes breathing develops. (4) Instances where respiratory control 
gets out of order; in conditions pertaining to the brain, in patients with decreased 
or disappeared chemosensitivity, hypercapnia is seen during wakefulness. These 
patients experience hypoventilation especially during REM stage. That is why in 
patients having central alveolar hypoventilation and obesity hypoventilation 
syndrome, the ventilation is further hindered during sleep; so hypoxia, hyper-
capnia, both central and obstructive apneas are observed [26–30]. Upper respira-
tory tract: it is a multipurpose conduit. As it allows for the passage of liquids and 
food, it is where activities like talking, swallowing and breathing take place. It 
contains the following structures: “Extrathoracic trachea, larynx, pharynx and 
nose”. The segment with the highest tendency to collapse in the respiratory 
system is the pharynx. The pharynx consists of three parts: (1) Nasopharynx is 
the part that extends from the nasal passage to the hard palate. (2) Oropharynx is 
divided into two parts as retropalatal and retroglossal fields. (3) Hypopharynx 
starts from the root of the tongue and extends to the larynx. In most of the 
patients with Obstructive Sleep Apnea Syndrome (OSAS), narrowing or closure 
of the airways that happen throughout the sleep takes place in the retropalatal 
and retroglossal region. For the preservation of the patency of the upper airways, 
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two important physiological mechanisms need to be in balance: (a) Forces that 
cause the collapse of the pharyngeal airways (the amount of soft tissue that 
covers the airways and the size of the airways). (b) Forces that dilate the pharyn-
geal airways (the activity of a muscle group that work in a coordinated manner to 
keep the airways open). Predisposing factors that would impair this balance are: 
“Mainly age and gender and then race, obesity, neck circumference, cigarette-
alcohol-sedative use, genetic factors, co-morbid diseases (acromegaly, hypothy-
roidism, Down Syndrome, storage diseases like amyloidosis and 
mucopolysaccharidosis), body posture and gravity, anatomic factors, genetic 
factors and hormones influence the patency of upper airways and constitute the 
risk factors for OSAS [31–35]. Sleep and immune system: among the substances 
that are both sleep inducing and immunologically active we can list; Interleukin-1 
(IL-1), IL-2, alpha interferon, Factor-S, muramyl peptides, tumor necrosis factor 
(TNF) and prostaglandin D2 (PGD2). We know that people who are sleep 
deprived can get sick more easily and when they pay attention to sleeping prop-
erly and resting, they heal faster. Several factors play a role in sleep regulation. 
TNF-alpha, IL-1-beta, growth hormone releasing hormone (GHRH), PGD2 and 
adenosine affect NREM sleep, whereas vasoactive intestinal peptide (VIP), nitric 
oxide (NO) and prolactin exert their effects on REM sleep. In the regulation of 
sleep-wakefulness, elements of immune system that are of significant value are; 
IL-1, IL-6 and TNF. When the endogenous production of IL-1-beta and TNF-
alpha increases (overnutrition, infectious disease states) NREM sleep increases. 
The effects of certain cytokines on sleep can be summarized as follows: 
Prosomnogenic cytokines: IL-1-beta, IL-1-alpha, TNF-alpha, IL-2, IL-6, IL-15, 
IL-18, epidermal growth factor, nerve growth factor, interferon-gamma, neuro-
trophins nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), 
neurotrophin 3, and 4 have been observed in elevated concentrations in allergic 
diseases, and they cause swelling and tenderness in the joints, and increase the 
tendency for autoimmune diseases like rheumatoid arthritis. The secretion of 
such factors by the immune system peaks during the early hours of the night and 
with gradual decreases they reach their lowest levels during morning hours. 
Short term sleep deprivation lead to decreases in natural killer (NK) cell activity, 
when this deprivation lasts longer there is an increase in NK cell activity. 
Experimental studies on laboratory animals have shown that, in instances of 
lengthened sleep deprivation fatal bacterial infections stemming from the 
gastrointestinal system can turn fatal within 3 days. In narcolepsy cases increases 
have been observed in TNF-alpha levels. In OSAS patients the circadian rhythm 
of secretion for TNF-alpha deteriorates significantly [36–40]. Endocrine 
Physiology during Sleep: Circadian rhythm and homeostatic balance provide for 
the control of hormonal and metabolic changes during sleep. Sleep deprivation 
studies analyze the effects of sleep and circadian rhythm on hormones. Based on 
these studies, growth hormone (GH) and prolactin (PRL) secretion increases 
during normal sleep, cortisol and thyroid stimulating hormone (TSH) secretions 
decrease. If sleep is interrupted by wakefulness, GH and PRL decrease while TSH 
and cortisol increase. Physiologically cortisol decreases starting from early hours 
of the morning towards the evening by reaching its lowest levels during the late 
hours of the day and initial hours of sleep. A couple of hours before waking up, 
there are reactivation of cortisol secretion. Low levels of cortisol is associated 
with slow wave sleep. During sleep deprivation the amplitude of cortisol rhythm 
decreases 15% compared to normal. Especially in elderly individuals who have 
fragmented sleep patterns, as deep sleep decreases as well, there is an increase in 
cortisol levels during night time and this is associated with decreased memory 
and increases in insulin resistance. In Cushing syndrome patients, due to bad 
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sleep quality decreases have been shown in REM latency, increases in first REM 
intensity and decreases of deep sleep. There are three basic processes coming into 
play in sleep regulation: (1) Homeostatic process: it tells us the relationship 
between last sleep and wakefulness periods. Sleep deprivation in the organism 
increases the duration and depth of sleep as a compensatory mechanism. (2) 
Circadian process: it is also defined as the biological clock. (3) Ultradian process: 
it defines the duration of REM—NREM sleep cycles and the interactions between 
them. Melatonin is the neuroendocrine modulator of day-night rhythm. 
Melatonin receptors are densely located at the suprachiasmatic nucleus (SCN). 
The endogenous circadian rhythm of melatonin secretion is in parallel to the 
endogenous rhythm of sleep tendency. Secretion of melatonin from the pineal 
gland is under the control of SCN. This pathway is multisynaptic and has contri-
butions from the sympathetic nervous system. Melatonin has three important 
physiological features: (1) Hypnotic effect: the ability to initiate sleep when 
homeostatic effect is inadequate to initiate or to maintain sleep. (2) 
Chronohypnotic effect: it is the ability to inhibit the time of waking-up that is 
normally regulated by the circadian center. (3) Chronobiotic effect: concerning 
the regulation of the circadian rhythm, it is the ability to initiate phase shifts and 
to do this during desired hours. The light that an individual is exposed to during 
night hours causes sudden decreases in melatonin levels. Beta blockers used for 
the prophylaxis of hypertension, cardiac arrhythmias and headaches block the 
sympathetic activity both at the heart and at the pineal gland. On the other hand, 
antidepressant drug fluvoxamine prevents the degradation of melatonin and 
increases its plasma concentrations. Neurotransmitter imbalance has been shown 
to be present in SCN of essential hypertension patients and there is a decrease in 
the secretion of melatonin in coronary artery disease that follows. These findings 
bring forward the possibility of using melatonin in hypertensive patients. At the 
beginning of sleep norepinephrine and epinephrine levels decrease and they 
reach their lowest levels within an hour. In patients with OSAS there is an 
increase in the levels of nocturnal catecholamines. Despite long hours of fasting 
during sleep, blood glucose levels have been shown to remain stable. Leptin that 
plays an important role in energy balance by suppressing appetite (produced by 
adipose tissue), increases significantly during sleep at night and thus increases 
slow wave sleep. In lengthened sleep deprivation, there is suppression of the 
night increases of leptin [41–45]. Gastrointestinal System: Gastric acid secretion 
has a circadian rhythm. Basal acid secretion is at its lowest during the hours of 
the day where there is no food intake, while it is at its highest during midnight. In 
healthy individuals, there is no relationship between gastric acid secretion and 
the stages of sleep. Together with the inhibition of acid secretion throughout the 
night (with H2 receptor blockers and proton pump inhibitors) the healing of 
duodenum ulcers could be shown. Small bowel and colon motility decrease 
during sleep. In studies conducted on patients with irritable bowel syndrome, 
significant lengthening of REM sleep was identified [46].
2.2.2  Basic signs in sleep disorders and pathophysiological causes (semiology, 
propedeutics, preliminary instruction, introduction to further study)
The first step in the evaluation of a patient with a sleep disorder is to iden-
tify the main symptom. A detailed history of the sleep and wakefulness cycle 
constitutes the second step. This is followed by the medical history of the 
patient, a list of previously used medications, family history, detailed informa-
tion about school, work, family and social life and a physical exam of bodily 
systems. Relevant laboratory tests are performed for differential diagnosis. 
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PSG establishes the definitive diagnosis. Despite developments in the field of 
sleep medicine, we see that neither the society nor the physicians are adequately 
informed about sleep and sleep disturbances. However, diseases associated with 
sleep are frequent in the population and can have significant consequences: they 
can negatively influence the individual’s “work or school success, social life, 
marriage and other relationships as well as leading to occupational and traffic 
accidents. Sleep disturbances can hinder the cognitive functions of an individual 
and can increase the risk of having psychiatric and other system related dis-
eases. Sleep apnea syndrome has a role in the etiology of severe diseases namely 
hypertension, myocardial infarction, heart failure, stroke and diabetes. Sleep 
deprivation can result in an increase in the number of seizures in a patient with 
epilepsy. Complaints of patients with diseases of other systems can be related 
to sleep disorders: in a patient having a follow-up with a Holter recording for 
hypertension, the reason behind an increase in blood pressure during sleep can 
be sleep apnea syndrome. Frequent arousals during the night, chest pain, not 
being able to climb the stairs during the day, tiredness, complaints about sleepi-
ness are evaluated as angina by cardiologists and angiograms are performed. 
However, a PSG to be performed on this patient can establish the correct 
diagnosis of central apnea syndrome. In a patient with goiter disease, during 
an overnight sleep test, it is possible to diagnose sinusal bradycardia. Likewise, 
patients having severe OSAS can have predominant depression symptoms and 
can therefore admit to psychiatry outpatient departments. Children admitting 
to pediatric neurology outpatient departments with sleep episodes are valuated 
multidimensionally and then treated for epilepsy. However, if these children 
were to undergo PSG and MSLT (multiple sleep latency test), correct diagnoses 
of underlying sleep apnea syndrome, central hypersomnia and narcolepsy could 
have been established.
Insomnia: it is described as “difficulty falling asleep or staying asleep”; short, 
inadequate, superficial, easily disruptable and non-restorative sleep. The 
amount of sleep an individual needs changes from one person to the other based 
on genetic traits. Some people carry out their daily functions with 5 hours of 
sleep a day, whereas others who do not sleep nine to 10 hours can feel bad the 
next day. Sleeplessness can be related to a primary disturbance related to 
mechanisms of sleep or can develop due to an underlying disease. Acute insom-
nia develops due to an abrupt change in environmental, physical or cognitive 
factors that initiate sleeplessness. Sleep complaints only disappear when the 
individual gets used to this new condition. There are different diseases underly-
ing primary insomnia; circadian rhythm disturbances, drug-substance use or 
sudden discontinuation of their use. Acquisition of behavior that hinders sleep 
hygiene can result in chronic insomnia. Psychophysiological insomnia is learned 
insomnia; the patient starts getting tense as the time for going bed approaches. 
This effort to get asleep and tension cause a performance anxiety and ends up 
being the main reason of insomnia. As the patient searches for behavioral 
changes to relieve herself of this anxiety, insomnia becomes inextricable: 
inadequate sleep hygiene, night eating (drinking) syndrome, alcohol-hypnotic-
stimulant related insomnia are examples to insomnia for which such behavioral 
changes and habits lay the foundation. Causes of pain that increase during the 
night that negatively affect sleep and trigger insomnia are: “entrapment neu-
ropathies, cluster headaches, arthritis, rheumatic pain, pain and paresthesia of 
the legs that are seen before falling asleep in restless leg syndrome. Most of the 
psychiatric diseases have a relationship with sleep: “In depression and anxiety 
disorder, insomnia might have started years ahead and likewise insomnia might 
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foreshadow psychosis or manic episodes.” Examinations of physical neurological 
and cognitive functioning of the patient might reveal important clues about 
insomnia. In anxiety, tachycardia, rapid breathing and cold hands; in sleep 
apnea syndrome, short and thick neck, obesity and narrow upper respiratory 
tract; in endocrine system pathologies hyperthyroidism characterized by 
excessive sweating and tachycardia, round face and buffalo hump in Cushing 
syndrome and neurological examination might reveal causes of insomnia like 
neuropathy and parkinsonism. It should be kept in mind that women with iron 
deficiency anemia may complain of insomnia. Excessive sleepiness: having 
somnolence at inappropriate times and in inappropriate environments and 
being unable to prevent it. Although somnolence might be related to the nature 
of the individual, to the wearisomeness of his daily life or to depression, it is an 
important symptom that forecasts sleep disorders. In its mild forms it is seen 
during rest, in advanced cases the patient might fall asleep during a conversa-
tion, while doing work, during eating or while driving. Hypersomnia leads to 
important work and traffic accidents. In differential diagnosis, daytime exces-
sive sleepiness due to chronic sleep deprivation should be kept in mind; addi-
tionally, excessive sleepiness can be seen during heart, kidney and liver failure, 
rheumatic, endocrinological and neurological diseases. Slowing down of 
responses, frequent yawning, closing of the eye lids, hesitance during speech or 
movements are the physical signs for excessive sleepiness. In people with 
chronic hypersomnia, round dark circles underneath the eyes attract one’s 
attention. Sleep disturbances where one can see hypersomnolence are: “sleep 
apnea syndrome, narcolepsy, idiopathic hypersomnia, parasomnias”; however, 
certain complaints that are obtained during history help in the differential 
diagnosis of these disease states. Such complaints are; “snoring, apnea episodes 
observed by close ones, morning headaches, nocturia, sleep paralysis, hypnogo-
gic hallucinations, cataplexy and confusion while waking up from sleep”. 
Idiopathic hypersomnia is characterized by increased sleep time and despite 
there is nothing that would hinder the quality of sleep, the individual feels 
himself sleepy which differentiates this condition from insomnia associated 
with sleep deprivation. Tiredness: patients who have excessive sleepiness also 
complain about tiredness and lack of energy. However, tiredness is not associ-
ated with tendency to fall asleep. Tiredness is an important symptom for many 
diseases. Especially in women, tiredness due to iron deficiency anemia is usually 
ignored and mostly confused with sleepiness and that is why women come to 
sleep laboratories. Endocrine and metabolic diseases, heart, kidney and liver 
failures and psychiatric conditions like depression can as well lead to tiredness 
and fatigue. Snoring: it is the sound generated during sleep due to the resonance 
of the tissues of the upper respiratory tract which is mostly heard during 
inspiration, rarely during expiration and sometimes during both phases. Due to 
narrowed upper respiratory tract the speed of the flowing air increases, this 
creates turbulence and increases the intensity of the sound. Patients are usually 
not aware of this and they are guided to a doctor by close ones who are bothered 
by the noise. Sometimes the patient wakes up with his own snoring or his own 
effort to breathe. Characteristic features of the snoring sound give clues as to 
whether the patient has sleep apnea or not. In patients who had undergone 
surgery for upper respiratory airways, apnea episodes might as well be seen in 
the absence of snoring. Sleep apnea: it is the stopping of respiration for 10 sec-
onds or longer during sleep. The patient’s partner or close ones describe it as an 
interruption of snoring, as patient holding his/her breath during sleep. During 
apnea the snoring stops, while the apnea ends the patient has a deep inhalation, 
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and the snoring restarts with a loud sound like roaring or snorting. These 
episodes can repeat hundreds of times through the night depending on the 
severity of the disease. The ending of apnea goes together with wakefulness 
reactions. This divides the sleep and hinders its quality. It might result in 
hypersomnia or insomnia. There are two main types of apnea: In central apnea 
air flow stops together with the effort of respiration. In obstructive apnea, air 
flow stops because of a narrowing in the upper respiratory tract but the effort of 
respiration still continues. Obstructive apnea is mainly accompanied by snoring 
and other complaints like night sweats, feeling of suffocation, nocturia, morn-
ing headaches, irritability, forgetfulness and depression and hypertension might 
follow. The patients are generally obese with short and thick necks; they also 
have narrow upper respiratory tracts. This body composition is not a rule 
though; people from all age groups including children might have obstructive 
apnea. Central apnea might be due to lesions of the brain stem and regions 
associated with the regulation of breathing. Furthermore, heart failure, meta-
bolic and toxic encephalopathies might lead to central apnea. Central apnea 
might happen both in sleep and during wakefulness. Night and morning head-
aches: their relationship with sleep disturbances and neurological diseases is 
important. In the presence of morning headaches, one should consider problems 
related to sleep and respiration. This headache is diffuse and blunt in nature and 
is related to a decrease in O2 saturation. Cluster headaches typically appear 
during REM sleep. Cataplexy: It is the sudden loss of muscular tonus triggered 
by intense emotional stimuli and physical exercise. It is described as muscular 
atonia or hypotonia ranging from couple of seconds to couple of minutes in 
duration. If this symptom is together with sleepiness during the day, then it is 
always related to narcolepsy. The fact that consciousness and memory are 
preserved during the incident differentiates cataplexy from syncope and 
epileptic seizures. Sleep paralysis: it is the carrying over of REM sleep related 
atonia to wakefulness. The duration of the incident is limited to seconds or 
minutes. When the episodes become more frequent and they last longer, this 
disturbs the patient significantly and even be frightening. Despite the patient is 
awake, visual and auditory hallucinations might be present. In order not to 
experience this situation during sleep, the individual avoids to sleep and devel-
ops insomnia. Narcolepsy, depression, alcohol use, sleep deprivation and shift 
changes are instances where this symptom might be seen. Hypnagogic and 
hypnopompic hallucinations: hallucinations taking place during the beginning of 
sleep are called hypnagogic, those appearing while the individual is about to 
wake up are called hypnopompic. These hallucinations might have visual, 
auditory and tactile components; they can either be pleasing or frightening. 
Other than being seen during narcolepsy, they can happen in instances of sleep 
deprivation or when there are changes in sleep patterns as well as following 
alcohol consumption. Parasomnias and movement during sleep: parasomnias are 
involuntary physical events that take place when an individual is about to fall 
asleep, during sleeping and when he/she is about to wake up. the activation of 
the central nervous system during parasomnias results in features caused by 
activation of autonomic nervous system and motor activity. NREM parasomnias 
are disturbances in waking up from NREM sleep and the most common are 
confusional arousals, sleep terror, and sleepwalking. They mainly appear during 
deep slow wave sleep especially during the first 1/3 of the night. Familial 
characteristics are prominent. Despite the patient might seem like awake during 
the incident, arousal is not complete and he does not interact with his surround-
ings, does not respond to external stimuli, is not easily arousable, resists to 
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efforts of waking him up and can show agitation. Patients are difficult to arouse 
during the event but if awaken they are confused; when episode ends, he can 
easily fall asleep after going to bed and does not remember the episode the next 
day. Movements associated with sleep: during REM sleep, muscle tonus disap-
pears. REM sleep behavioral disturbance (RBD) is a parasomnia associated with 
REM sleep during which muscle tonus does not disappear but increases. As a 
result of this, the patient starts playing her/his dreams. It is characterized by 
aggressive behavior like speaking, shouting, kicking, punching or slapping, 
jumping, running which include violence and might harm the patient herself 
and her bed partners. The most important difference of arousal disturbances 
from NREM parasomnias is the development of episodes towards morning 
hours when REM sleep intensifies, when the patient wakes up after the episode, 
he is not confused and can remember a dream that can explain her/him behavior 
during which s/he has frequently felt threatened. Most of the patients are in the 
advanced age group and are idiopathic cases. Associated neurological diseases 
are “Parkinson’s, Multisystem Atrophies and Dementia with Levy Bodies”. The 
condition can also be seen in individuals using tricyclic antidepressants, mono-
amine oxidase inhibitors and serotonin reuptake inhibitors and in those who 
have recently stopped consuming alcohol. Talking during sleep: these are vocal-
izations ranging from murmuring to meaningful conversation during superfi-
cial NREM sleep. They can rarely be seen during REM stage as well. Stress, 
febrile diseases and frequent sleep deprivation can result in this. There is no 
need for treatment if there is not any underlying sleep disturbance. Bruxism: it 
is a movement disorder characterized by repetitive rhythmical jaw clenching 
and ensuing teeth grinding. It increases with stress and can result in face pain, 
jaw pain, teeth pain and damage to the teeth and even breaking of teeth as well 
as jaw dislocation. Rhythmical movement disorder: these are stereotypical move-
ments that start immediately before falling asleep and continue during superfi-
cial sleep. The most known one is to rhythmically knock the head on the pillow 
or the headboard. It is a phenomenon usually encountered during infancy or 
early childhood and it disappears with increasing age by decreasing in intensity. 
Restless leg syndrome (RLS) and periodical leg movements (PLM) during sleep: RLS 
usually appears during evening hours and mostly after going to bed. These are 
unpleasant leg symptoms that cannot be well expressed by the patients. The 
disturbing sensation leading to an irresistible need to move the legs is the most 
important feature. As symptoms disappear with movement, patients constantly 
move their legs while in bed and they can even stand up and start walking 
around after a while. When patients come to see a physician with the complaint 
of insomnia, antidepressants that might be prescribed for treatment can 
increase the severity of RLS. Other causes that can increase the severity of the 
symptoms can be listed as: “Iron deficiency anemia, B12 and folate deficiencies, 
uremia, spinal cord lesions, diabetes mellitus, peripheral neuropathies, exces-
sive exercise and caffeinated beverages”. Signs in children: although they might 
be non-specific, the physician should definitely take sleep disturbances into 
consideration in children coming with the following complaints: 
“Developmental delay, decrease in school performance, distractibility, hyperac-
tivity, moodiness, stubbornness and aggression”. School-age children can admit 
to doctors with complaints of feeling themselves not rested throughout the day, 
not having slept enough, difficulty in concentrating, adenoid hypertrophy, lack 
of attention and sleepiness during classes. In the presence of such symptoms, 
diagnoses of sleep apnea, insomnia, RLS, hypersomnia and narcolepsy should 
be considered [47–54].
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